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Renal function and glomerular hemodynamics in male
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Renal function and glomerular hemodynamics in male endotoxemic
rats. The renal effects of a single intravenous dose of two different E.
coli lipopolysaccharides (LPS 0111 :B4 and LPS 0127:B8), at the same
dose of 100 pg/kg, were evaluated in euvolemic Munich-Wistar (MW)
rats by whole kidney clearance techniques and micropuncture studies.
Following LPS infusion, a significant decrease (8%) in mean BP was
observed only in the LPS 0127:B8 treated group. Inulin clearance fell
57% (LPS Olll:B4), P < 0.01, and 38% (LPS 0127:B8), P < 0.01.
Para-aminohippuric (PAH) clearance decreased 31% (P < 0.01) and
total effective renal vascular resistance rose 70% (P < 0.03) in response
to LPS 0111 :B4. No significant change in PAH clearance was noted in
the LPS 0l27:B8 group. Superficial single nephron glomerular filtration
rate (SNGFR) was reduced 69% (LPS Olll:B4), P < 0.03, and 33%
(LPS 0l27:B8), P < 0.02. Superficial glomerular plasma flow fell 48%
(LPS Olll:B4), P < 0.03, and 24% (LPS 0127:B8), P < 0.03. Both
lipopolysaccharides were associated with an increase in afferent arte-
riolar resistance (RA) whichaccounted for a reduction in the glomerular
capillary hydraulic pressure (0). There was no change in the proximal
tubular pressure in either group and, therefore, the net transcapillary
hydraulic pressures were reduced. No measurable change in the ultrafil-
tration coefficient, K, was observed in either group. In a second set of
protocols, the effect of prior administration of indomethacin or capto-
pril on LPS 0111 :B4 action was investigated. A significant decrease in
BP occurred when animals were pretreated with captopril. Both indo-
methacin and captopril prevented the renal effects of LPS 0111:84. The
data indicate that lipopolysaccharides affect the kidney primarily by
causing a selective increase in RA. They also indicate that the nephro-
toxic potential of the lipopolysaccharides studied are not equipotent.
Finally, the results from indomethacin and captopril groups suggest that
hormonal alterations play a role in the LPS-induced renal hemodynamic
changes.
Acute renal failure is a frequent accompaniment of endotox-
emia [1]. The pathophysiological events that occur in sepsis,
however, are not fully understood. Hypotension, when present,
may contribute to the renal failure of septicemia. The acute
renal failure, however, is not entirely dependent on hypoten-
sion. Renal alterations varying from minimal impairment to
acute tubular necrosis [2, 3] and bilateral cortical necrosis [4, 5]
have resulted from the acute administration of bacterial endo-
toxins, some of them in the absence of hypotension [2, 4, 6].
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The mechanisms by which endotoxin exerts its renal effects
have received considerable attention. Eicosanoids [6, 7], renin
and angiotensin [4, 8], renal nerves [8] and adenosine [91 have
all been implicated in the genesis of the renal abnormalities of
endotoxemia. Few studies, however, have investigated the
renal hemodynamic changes that occur with endotoxemia.
Conger, Falk and Guggenheim [4] studied the renal hemody-
namic effects of a relatively high dose of lipopolysaccharide
(LPS) infusion ('—6 mg/kg) in postpartum Munich-Wistar rats.
In this setting, the infusion of LPS uniformly resulted in
bilateral cortical necrosis. Utilizing micropuncture techniques,
they found that the early deterioration in inulin and PAH
clearances was due to alterations in glomerular hemodynamics.
It should be noted that a small but significant decrease in renal
function was observed in virgin controls receiving the same
dose of LPS. Unfortunately, the mechanisms related to the
reduction of renal function in virgin animals were not addressed
in that study, since micropuncture studies were not performed
in the control group. The acute renal failure associated with
endotoxemia, however, does not occur exclusively in the
peripartum period. Furthermore, cortical necrosis is frequently
not the histological lesion associated with sepsis. For these
reasons, the present study was undertaken to evaluate glomer-
ular hemodynamics in euvolemic male rats infused with a dose
of LPS which results in ARF but not cortical necrosis [6]. Two
endotoxins derived from different strains of E. co/i were studied
to determine if variations in the type of endotoxin used could
explain some of the differences observed between studies.
Since previous studies have reported that plasma renin activ-
ity is elevated in endotoxemia [8, 10] and that administration of
a competitive angiotensin II inhibitor may in part protect the
kidney [4], the renal effect of LPS in the presence of captopril
was assessed. Finally, cyclo-oxygenase products such as
thromboxane A2, prostaglandin E2 and 12, are elevated in
endotoxemia [4, 9, 14], while cyclo-oxygenase inhibition has
been consistently associated with improvement of the systemic
hemodynamics and increased survival in endotoxemia [11—141.
Thus, the effect of indomethacin was also investigated in the
present model.
Methods
General
Studies were performed on five groups of male Munich-
Wistar rats weighing 230 to 330 g. Each rat was allowed free
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access to water and standard rat chow until the morning of the
study.
Rats were anesthetized with mactin (BIK, Germany), 100
mg/kg i.p., placed on a thermostatically controlled table, and
their temperature monitored with an electronic thermometer
(Simpson Co., Chicago, Illinois, USA). Following tracheosto-
my, the left femoral artery was catheterized with a PE-50
polyethylene tubing and approximately 60 .tl of arterial blood
was collected for baseline hematocrit (Hct) and protein (CA)
determinations. This arterial catheter was used for blood sam-
pling and monitoring of mean femoral arterial pressure. Poly-
ethylene catheters were also inserted into the right and left
jugular veins. An infusion of an inulin and para-aminohippuric
acid (PAH) containing saline solution at 1.2 ml per hour
(Harvard Co., South Natick, USA) was started in the right
jugular vein and continued throughout the entire experiment.
Surgical losses were replaced via the left jugular vein with
isoncotic rat serum at a rate calculated to maintain the animals
euvolemic [15]. Laparotomy was performed through a median
incision and a PE-lO polyethylene catheter was introduced into
the left ureter for collection of timed urine samples.
Following an equilibration period of 45 minutes, control
collections were begun. Two timed urine samples and two
blood samples of approximately 60 xl each were collected for
Hct, CA, and plasma and urinary determinations of inulin,
PAH, sodium and potassium.
At the end of the control period, 100 xg/kg body wt of either
E. coli 01ll:B4 LPS (Difco Labs, Detroit, Michigan, USA) or
E. coli 0127:B8 (Sigma Chemical Co., St. Louis, Missouri,
USA) was given as an intravenous bolus. In the control group,
an equivalent volume of saline (vehicle) was substituted for
endotoxin. Following a second equilibration period of 50 min-
utes to allow a maximal effect of LPS [61, repeat collections
were performed.
Micropuncture studies
In Groups 2 and 3, animals were set up as above. In addition,
the posterior face of the left kidney was cautiously detached
from its retroperitoneal fat and supported on a plastic shovel. A
plastic holder was placed to minimize transmission of diaphrag-
matic movements to the kidney. Exactly timed (I to 3 mm)
samples were collected from a minimum of three proximal
convoluted tubules for determination of flow rate and inulin
concentration and calculation of single nephron glomerular
filtration rate (SNGFR). Coincident with these collections,
samples of femoral arterial blood were obtained in each period
for determination of Hct, total protein, inulin and PAH concen-
trations.
Measurements of hydraulic pressures were obtained from
punctures of glomerular capillaries (PGC), proximal tubules
(PT), and efferent arterioles (PEA) with 2 to 4 m pipets
containing 2.0 M sodium chloride connected to a continuous
recording servonull-transducer system (1PM, San Diego, Cali-
fornia, USA). Hydraulic output from the servo-system was
channeled via an electronic transducer (Statham Instruments
Division, Gould Inc., Hato Rey, Puerto Rico) to the second
channel of the recorder.
The afferent arteriolar oncotic pressure (IrA) and efferent
arteriolar oncotic pressure (IrE) were estimated from the plasma
protein concentrations of femoral artery (CA) and superficial
efferent arterioles (CE) as previously described [16]. These
estimations permit calculation of colloid osmotic pressures,
single nephron filtration fraction (SNFF), glomerular capillary
plasma flow (QA), afferent (RA), efferent (RE), total (RT = RA +
RE) arteriolar resistance, and the glomerular capillary ultrafil-
tration coefficient (Kr) using equations described elsewhere [17,
18].
Characterization of groups
Group 1, control (N = 6), received an injection of saline (1
mi/kg) at the end of the first period to evaluate the effects of
time, vehicle and procedures on renal function.
Group 2 (N = 12) received a single dose of intravenous LPS
Olll:B4, 100 j.g/kg in saline (100 gJml) at the end of the first
period enabling evaluation of the effects of LPS on renal
function and glomerular hemodynamics. Complete micropunc-
ture data were collected in six animals of this group.
Group 3 (N = 8) underwent a protocol identical to that of
Group 2 except LPS 0127:B8 was injected rather than LPS
Olll:B4.
Group 4 (N = 6) was designed to assess the effect of
pretreatment with an inhibitor of cyclo-oxygenase on the renal
effects of LPS. Animals received an i.v. bolus of indomethacin
(2 mg/kg), immediately following catheterization of the left
jugular vein. As in Group 2, they also received LPS 0111 :B4 at
the end of the first period.
Group 5 (N = 6), was designed to investigate the effect of
pretreatment with captopril, a converting enzyme inhibitor, on
the renal action of LPS. Animals received a continuous infusion
of captopril (Squibb, Princeton, New Jersey, USA; 2 mg/kg per
hr) which was begun at the time of the left jugular vein
catheterization and continued throughout both experimental
periods. LPS (Olll:B4) was infused at the end of the initial
period, as in Group 2.
Analytical procedures
The concentration of inulin in the tubule fluid was measured
by the microfluorescence method of Vurek and Pegram [19].
Inulin and PAH concentrations in plasma and urine were
determined by the macroanthrone method of Fuhr, Kaczmarc-
zyk and Kruttgen [20] and by the method of Smith et al [21],
respectively. Protein concentrations in femoral artery plasma
for all groups were determined by refractometry and corrected
according to a curve constructed by the method of Lowry
modified by Schachterle [22]. In Group 2, CA was determined
by the ultracolorimetric method of Viets et al [23] used for CE
to permit adequate comparison. Sodium and potassium concen-
trations in plasma and urine were measured by flame photom-
etry (Tecnov, Sao Paulo, Brazil). Plasma activity of renin was
determined by the method of Vieira et al [24].
Glomerular filtration rate (GFR) was estimated by inulin
clearance and effective renal plasma flow (ERPF) by PAH
clearance. Total effective renal vascular resistance (ERVR) was
calculated as the BP/ERPF ratio. Values of GFR and ERPF
were corrected for kidney weight.
Statistical analysis
Data from the first and second periods in each group were
compared using a signed rank test. The Rank Sum Test was
used for comparing data between groups 2 and 3. Changes
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Table 1. Summary of whole animal data
Body weight Kidney weight BP mm Hg
I
Hct %
2
CA gid!
g 1 2 1 2
Group 1 277 14 1.08 0.06 104 3 106 3 46 1 46 1 5.8 0.1 5.8 0.1
Control
Group 2 266 5 1.01 0.03 109 3 102 3 47 1 48 1 5.5 0.1 5.4 0.1
LPS Olll:B4
Group 3 265 6 1.03 0.05 104 3 96 2 45 I 46 I 5.3 0.1 5.2 0.1
LPS 0127:B8
Group 4 267 5 1.04 0.03 111 5 115 5 48 1 49 1 5.5 0.1 5.3 0.2
Indomethacin and
LPS 01l1:B4
Group 5 282 12 1.12 0.06 102 4 90 4 47 1 47 1 5.7 0.2 5.5 0.1
Captopril and
LPS 011l:B4
Values are expressed as the mean SEM. Abbreviations are: 1, values at first period; 2, values at second period; BP, blood pressure; Hct,
hematocrit; CA, plasma protein concentration of femoral artery.
a P < 0.05 vs. values at first period
Table 2. Summary of several measures of whole kidney function
GFR ERPF ERVR
mm Hg minim!
V
pJ/min
UNaV
pEg/mm
FENa
%
UKV
p.Eq/mmn
FEK
%mi/mm
Group 1
Control 1 0.96 0,07 3.38 0.15 31.14 1.57 2.6 0.2 0.45 0.08 0.30 0.04 1.07 0.14 49.68 7.83
Control 2 1.14 0.05 3.65 0.22 29.56 1.92 3.0 0,2 0.63 0.12 0.35 0.05 1.46 0.21 60.35 16.48
Group 2
Control 0.91 0.03 3.09 0.14 36.31 2.41 3.2 0.5 0.88 0.17 0.59 0.11 1.22 0.12 62.00 9.95
LPSO11I:B4 0.39 0.05a 2.13 0.29a 63.07 I1.65 3.1 0.3 0.21 0.03a 0.38 0.05 0.35 o.osa 53.98 6.76
Group 3
Control 1.04 0.07 3.48 0.27 30.95 2.43 3.5 0.6 0.90 0.22 0.47 0,14 1.24 0.18 46.36 8.98
LPS 0127:B8 0.61 0.04a 3.01 0.36 35.71 5.16 4.7 0.8 0.43 0.12 0.45 0.12 0.68 0.09 35.82 4.35
Group 4
Indomethacin 1.00 0.09 3,53 0.38 35.67 4.98 2.8 0.4 0.68 0.17 0.43 0.09 0.98 0.17 50.70 10.71
Indomethacin + LPS 1.03 0.16 4.26 0.79 38.35 5.32 4.9 1.4 1.09 0,45 0.49 0.15 1.06 0.31 43.10 11.37
Group 5
Captopril 0.94 0.05 3.89 0.43 38.25 3.78 3.3 0.4 0.89 0.24 0.58 0.15 1.50 0.20 93.15 13.73
Captopril + LPS 0.90 0.14 5.02 0.75 19.25 1.94 4.2 0.7 0.58 0.22 0.35 0.11 0.95 0.26 68.18 19.58
Values are expressed as the mean SEM. Abbreviations are: GFR, glomerular filtration rate; ERPF, effective renal plasma flow; ERVR, effective
renal vascular resistance; V. urine flow rate; UNaV, urinary excretion of sodium; FENa, fractional excretion of sodium; UKV, urinary excretion
of potassium; and FEK, fractional excretion of potassium.
a P < 0.05 vs. values at first period
among groups 1, 2, 4, and 5 were evaluated by a Kruskal-Wallis
test complemented by a Dunn variation.
Statistical significance was considered as P < 0.05. Results
are expressed as mean SE.
Results
The results of the whole animal data in the five groups are
summarized in Table 1. All groups had similar body weights.
Significant decreases of 8 and 12% were observed in the mean
arterial pressure in the second period of Groups 3 (P < 0.04)
and 5 (P < 0.04), respectively. A small but statistically signifi-
cant reduction in CA was observed in Group 4.
Renal action of LPS
Table 2 summarizes parameters of whole kidney function. All
studied parameters remained constant throughout the experi-
ment in the control group (Group I). Treatment with E. coli
0111 :B4 LPS (Group 2) induced a 57% decline in GFR (P <
0.01) and a 31% decrease in PAH clearance (P < 0.01) in
association with a 74% increase in total renal vascular resis-
tance (P < 0.03). The sodium and potassium excretion rates
were reduced 76% (P <0.01) and 71% (P < 0.01), respectively,
but no alteration was found in the urinary flow rate. In contrast,
E. coil 0127:B8 infusion (Group 3) reduced the GFR only 38%
(P < 0.01) without significantly affecting either the PAH clear-
ance or effective renal vascular resistance. The urinary excre-
tion rate of potassium declined 45% (P < 0.02). There was also
a tendency for Na excretion to fall but this did not reach
statistical significance. As in Group 2, the urinary flow rate
remained unchanged (Table 2). The percent changes induced by
the two LPS's in inulin clearance and PAH clearance were
statistically different, 57% versus 38% (P < 0.05), and 31%
versus 14% (P < 0.04), respectively.
Micropuncture data obtained in six animals of Group 2 and
seven animals of Group 3 are depicted in Table 3. In Group 2,
SNGFR, QA and SNFF were all significantly reduced by E. coli
011 1:B4 LPS infusion, 69% (P < 0.03), 48% (P <0.03), and 37%
(P < 0.03), respectively. Since P0 declined from 44 1 to 36
Lugon et a!: Hemodynamics in endotoxemic rats 573
Table 3. Glomerular hemodynamic measurements before and after LPS administration—Groups 2 and 3
SNGFR QA
ni/mm SNFF
GC 'T P RA RE RT CA CE
gIdi
A
mm
ITE
Hg E/P
K1
ni/sec
mm Hgmm Hg x 1010 dyn sec cm5
Group 2 LPS 0111:B4
Before 35.48 102.55 0.35 44 12 32 2.79 1.52 4.31 5.4 8.3 17.54 33.82 1.06 0.086
After 10.83a 52.87a 0.22u 36 11 25 5.62a 2.07 7.69a 5.4 6.9 17.22 25.50 1.05 0.080
Group 3 LPS 0127:B8
Before 34.17 97.50 0.35 45 16 29 2.62 1.43 4.04 5.0 7.7 15.59 30.36 1.03 0.082
After 22.76a 74.58a 0.30 35 12 23 3.90a 1.47 537 5.0 7.2a 15.38 26.80a 1.19 0.089
Values are expressed as mean scm. Abbreviations are: SNGFR, single nephron glomerular filtration rate; QA, glomerular plasma flow;
SNFF, single nephron filtration fraction; GC, glomerular capillary hydraulic pressure; P-1-, proximal tubular hydraulic pressure; zP,
transcapillary hydraulic pressure; R, arteriole resistance; C, plasma protein concentration; ir, plasma oncotic pressure and I(f, glomerular
capillary ultrafiltration coefficient. Subscripts are: A, afferent and E, efferent.
P < 0.05 vs. before LPS
2 mm Hg (P < 0.03) and P1- did not change, zP, the net
hydrostatic pressure decreased from 32 ito 25 2 mm Hg (P
< 0.03). A 101% increase was observed in RA (P < 0.03), but
RE remained unchanged (Table 3). Mean values for CA and,
thus ITA, were similar before and after LPS administration.
Consequent to the reduction in SNFF, however, CE and thus,
decreased significantly (P < 0.03). Despite euvolemic con-
ditions, filtration disequilibrium (ITEIzW < 1) was obtained in
both periods in only two rats. Two other animals were at
filtration equilibrium in both periods. Of the two remaining rats,
one changed from equilibrium to disequilibrium, the reverse
being observed with the other. When the data are considered
together, there is no indication that a reduction in K1 plays a
role in LPS induced decrease in SNGFR.
Less severe alterations were observed in the glomerular
hemodynamics after infusion of LPS 0127:B8 (Group 3). Mean
SNGFR, QA and SNFF were reduced 33% (P < 0.02), 24% (P
<0.03) and 14% (P < 0.02), respectively. GC fell from 45 1
to 35 1 mm Hg (P < 0.02) leading to a reduction in P, from
29 ito 23 1 mm Hg (P < 0.02). A 49% increase was noted
in RA (P < 0.05). Most of the animals were at filtration
equilibrium, the calculated K1 representing a minimum in six
rats prior to LPS and in five rats after LPS administration. With
this limitation, no data to support a role for Kf in the pathogen-
esis of endotoxin-induced acute renal failure were found.
Effects of pretreatment with indomethacin and captopril
Rats pretreated with indomethacin (Group 4) did not demon-
strate any significant change in BP (Table 1). In the group
pretreated with captopril, LPS 0111:B4 infusion caused a 12%
reduction in BP (P < 0.04). Both experimental maneuvers,
however, were effective in preventing LPS 0111:B4 actions on
GFR, ERPF, ERVR, UNaV and UKV (Table 2).
Plasma renin activity was measured at the end of experiments
in three animals of Group 2 (LPS 0111:B4), and 4 animals of
Group 4 (indomethacin + LPS 0111:B4). Mean values were ten
times higher in Group 2 (2.39 0.09 ng ml hr') versus
Group 4(0.23 0.08 ng m1 1 hC1), P < 0.04, suggesting that
the inhibition of prqtaglandin synthesis may have secondarily
affected the renin-angiotensin system.
Discussion
Endotoxin is felt to be a mediator of sepsis-induced acute
renal failure. Recent data indicate that endotoxins reduce renal
function by modifications in renal hemodynamics independent
of changes in arterial pressure [2, 4, 6]. In agreement with these
studies, the reduction in BP following LPS infusion in the
present study cannot account for the renal findings. Indeed, the
decrease in GFR was greater with LPS 0111:B4 which was not
associated with a significant effect on the BP.
Conger et a! [4] investigated the renal hemodynamic effects of
E. co/i 026B LPS, —6 mg/kg, in hydropenic female rats in the
postpartum period. They reported a fourfold increase in RA and
a twofold increase in RE. Their findings, however, resulted from
a combination of factors unique to the postpartum period. In
their study the animals developed cortical necrosis, a lesion
which is rarely observed with sepsis. Furthermore, virgin
controls receiving the same dose of LPS had a small but
significant decrease in their renal function. The present set of
studies was undertaken to determine if alterations in intrarenal
hemodynamics are important in a more general model of
endotoxin-induced acute renal failure. Male rats were investi-
gated to avoid any possible influence of pregnancy or the estral
cycle on the sensitivity to bacterial endotoxins. A dose of
endotoxin which does not cause cortical necrosis was selected
[6]. To determine if variations in the type of endotoxin would
explain some of the differences between studies, endotoxins
derived from two different strains of E. co/i were used.
The infusion of LPS significantly altered both the whole
kidney function and the single nephron function. The parame-
ters obtained from the whole kidney studies revealed that LPS
0111 :B4 reduced both the inulin clearance and the PAR clear-
ance, and increased the total effective renal vascular resistance.
LPS 0127:B8 also decreased inulin clearance but did not signif-
icantly affect either the PAR clearance or the renal vascular
resistance. It should be noted, however, that consistent with
reports of others [2, 3, 6] LPS Olil:B4 decreased the inulin
clearance proportionately more than the PAH clearance (57%
vs. 31%, P < 0.01). Considering the smaller reduction in the
inulin clearance by LPS 0127:B8, therefore, the absence of a
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significant alteration in either the PAH clearance or the total
renal vascular resistance in this group is not as surprising. The
infusion of both lipopolysaccharides reduced the urinary excre-
tion of sodium and potassium to the same degree as the GFR
resulting in no net change in the fractional excretion of these
cations. The decreased potassium excretion was interpreted as
probably determined by a reduction of distal delivery of so-
dium.
Overall, the results of the whole kidney function studies and
those of the micropuncture studies are quite consistent. The
micropuncture studies revealed that in superficial nephrons,
both lipopolysaccharides significantly reduced the SNGFR and
the glomerular plasma flow, and significantly increased the total
arteriolar resistance. A comparison of the micropuncture data
and the whole kidney data suggests, however, that the reduc-
tion in plasma flow might be more accentuated in superficial
than in deep nephrons. For instance, if only the animals which
had undergone micropuncture are considered, LPS 0111 :B4
reduced PAH clearance 38% while, in superficial nephrons,
glomerular plasma flow was decreased 48%. No statistically
significant difference was evident, however. It should be noted
that a previous study by Kikeri et a! [31 reported that PAH
extraction was decreased when a 53% reduction in GFR fol-
lowed LPS infusion, suggesting that PAH clearance, in this
circumstance, may underestimate the renal plasma flow. Since
single nephron plasma flow is a direct calculation it would not
be affected by alterations in PAH extraction. The reduction in
the whole renal plasma flow in the LPS 0111: B4 group might
therefore be less than the calculated 38% and perhaps signifi-
cantly less than the 48% reduction in the glomerular plasma
flow of superficial nephrons. No decrease in PAH clearance,
however, was found in the LPS 0127:B8 group, suggesting that
PAH extraction was not substantially changed when only a
modest impairment in GFR was present. Despite this, a 24%
reduction was observed in the glomerular plasma flow of
superficial nephrons, again indicating that a greater reduction in
the perfusion of superficial nephrons might take place in endo-
toxemia.
Although the renal effects of LPS 0111 :B4 were more marked
than those from LPS 0127:B8, their effects on renal parameters
were qualitatively similar. The present findings suggest that in
relatively low dose lipopolysaccharides exert their renal effects
primarily by increasing afferent arteriolar resistance. This leads
to a reduction in the glomerular capillary hydraulic pressure
which, in the presence of an unaltered tubular pressure, results
in a significant decrease in glomerular transcapillary hydraulic
pressure. In contrast to the findings in postpartum rats [4], no
change was observed in the efferent arteriolar resistance. In
agreement with that report, however, no measurable change in
the ultrafiltration coefficient, Kf, was detected in our series,
though the presence of filtration equilibrium in a number of the
animals precludes any definitive conclusion in this regard. The
decrease in glomerular plasma flow and SNGFR seems to be
entirely accounted for by the increase in RA.
Additional studies utilizing whole clearance techniques were
performed to assess the effect of prior administration of indo-
methacin and captopril on the renal effects of the LPS 0111 :B4.
A significant modification of the degree of renal impairment was
found with both of these agents. Indomethacin pretreatment
completely prevented the reduction in the inulin clearance,
PAH clearance, sodium and potassium excretion. Since cyclo-
oxygenase inhibition is thought to impair the renal function of
hypoperfused kidneys [25, 26, 27], these findings were unex-
pected. In support of the present observations, however, there
are several intriguing reports of indomethacin-associated in-
crease in survival in animal models of sepsis [11, 13, 281. There
are, in addition, reports that cyclo-oxygenase inhibition can be
protective against the LPS-induced blood flow reduction in the
denervated kidney of dogs [8] and in the liver and kidney of rats
[29]. Cyclo-oxygenase inhibition is expected to result in a
decrease in both vasodilatory and vasoconstrictive derivatives
of arachidonic acid metabolism. Our present results suggest
that vasodilatory prostaglandins may not be the only system to
influence renal hemodynamics in endotoxemia. Inhibition of
vasoconstrictive cyclo-oxygenase product synthesis like throm-
boxane A2 may have had beneficial effects. Consistent with this
view, Badr, Kelly and Brenner [6] reported that a selective
inhibitor of thromboxane A2 attenuated the renal effects of
endotoxin. It is also possible that inhibition of prostaglandin-
dependent angiotensin II production may have played a protec-
tive role. The latter is consistent with the lower plasma renin
activity in animals receiving indomethacin in the present study.
Reduced renin production following indomethacin was also
reported by Heinrich et al [8] in the denervated kidney of dogs
whose glomerular filtration rate was maintained after endotoxin
administration.
Pretreatment of animals with captopril also prevented the
LPS-induced decrease in inulin clearance, PAH clearance, and
sodium and potassium excretion despite an accentuation in the
hypotensive effect of LPS. Since captopril can potentially
interfere with kinin catabolism as well as angiotensin II produc-
tion [30] it is not possible to draw any definitive conclusion
regarding the mechanism responsible for this protection, from
our studies. Considering, however, that Conger et al [4] re-
ported that the renal effects of LPS were partially prevented by
a competitive angiotensin II inhibitor, it is reasonable to con-
clude that at least part of the protection offered by captopril
might be due to the inhibition of angiotensin II production. The
present observations suggest that angiotensin II, which is
thought to act mainly in effe rent arterioles [31, 32], may have an
important afferent arteriolar effect in the presence of LPS.
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Appendix. Abbreviations
blood pressure
plasma protein concentration of femoral artery
plasma protein concentration of star vessel
fractional excretion of sodium
fractional excretion of potassium
glomerular filtration rate
BP
CA
CE
FENa
FEK
GFR
Lugon et a!: Hemodynamics in endotoxemic rats 575
hematocrit
glomerular capillary ultrafiltration coefficient
lipopolysaccharide
star vessel hydraulic pressure
glomerular capillary hydraulic pressure
proximal tubular hydraulic pressure
transcapillary hydraulic pressure (P =
GC PT)
femoral artery oncotic pressure
star vessel oncotic pressure
para-aminohippurate
glomerular plasma flow
afferent arteriole resistance
efferent arteriole resistance
effective renal plasma flow
effective renal vascular resistance
single nephron filtration fraction
single nephron GFR
urinary excretion of sodium
urinary excretion of potassium
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